The DOI matches its Crossref record.
Bioavailability of Antibiotics and Their Toxicity
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Oral antibiotics have a reduced bioavailability, around 50% of MNC is metabolized by the first pass metabolism in the liver [11].”
From Formulation and Characterization of PLGA Minocycline Microneedles for Enhanced Skin Deposition and Antibacterial Activity in Acne Treatment (2025) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 201
- Abramowicz M (2003) Hypoglycemia and hyperglycemia with fluoroquinolones. Med Lett Drugs Ther 45:64–64
- Abu-Basha E, Gehring R, Hantash T, Al-Shunnaq A, Idkaidek N (2009) Pharmacokinetics and bioavailability of sulfadiazine and trimethoprim following intravenous, intramuscular and oral administration in ostriches (Struthio camelus). J Vet Pharmacol Ther 32:258–263 · doi:10.1111/j.1365-2885.2008.01036.x
- Actor P, Chow AW, Dutko FJ, McKinlay MA (2000) Chemotherapeutics. Ullmann’s Encyclopedia of Industrial Chemistry · DOI
- Agarwal A, Kharb V, Saharan VA (2014) Process optimisation, characterisation and evaluation of resveratrol-phospholipid complexes using box-Behnken statistical design. Int Curr Pharmaceut J 3:301–308 · doi:10.3329/icpj.v3i7.19079
- Agwuh KN, MacGowan A (2006) Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines. J Antimicrob Chemother 58:256–265 · DOI · Paper page
- Albarellos GA, Montoya L, Passini SM, Lupi MP, Lorenzini PM, Landoni MF (2016) Pharmacokinetics of meropenem after intravenous, intramuscular and subcutaneous administration to cats. J Feline Med Surg 18:976–980 · doi:10.1177/1098612x15604655
- Aldred KJ, Kerns RJ, Osheroff N (2014) Mechanism of quinolone action and resistance. Biochemistry 53:1565–1574 · DOI · Paper page
- Allam AN, El Gamal S, Naggar V (2011) Bioavailability: a pharmaceutical review. Int J Novel Drug Deliv Tech 1:77–93
- Ambrose PJ (1984) Clinical pharmacokinetics of chloramphenicol and chloramphenicol succinate. Clin Pharmacokinet 9:222–238 · DOI
- Ambrose CT, Coons AH (1963) Studies on antibody production: VIII The inhibitory effect of chloramphenicol on the synthesis of antibody in tissue culture. J Exp Med 117:1075–1088 · DOI · Paper page
- Appel GB, Neu HC (1977) The nephrotoxicity of antimicrobial agents. N Engl J Med 296:663–670 · doi:10.1056/nejm197703242961205
- Baert K, De Baere S, Croubels S, De Backer P (2003) Pharmacokinetics and oral bioavailability of sulfadiazine and trimethoprim in broiler chickens. Vet Res Commun 27:301–309 · doi:10.1023/a:1024084108803
- Bahal N, Nahata MC (1992) The new macrolide antibiotics: azithromycin, clarithromycin, dirithromycin, and roxithromycin. Ann Pharmacother 26:46–55 · doi:10.1177/106002809202600112
- Balbi H (2004) Chloramphenicol: a review. Pediatr Rev 25:284–288 · DOI
- Ball P, Mandell L, Patou G, Dankner W, Tillotson G (2004) A new respiratory fluoroquinolone, oral gemifloxacin: a safety profile in context. Int J Antimicrob Agents 23:421–429 · doi:10.1016/j.ijantimicag.2004.02.014
- Bargoni A, Cavalli R, Zara GP, Fundarò A, Caputo O, Gasco MR (2001) Transmucosal transport of tobramycin incorporated in solid lipid nanoparticles (SLN) after duodenal administration to rats. Part II—tissue distribution. Pharmacol Res 43:497–502 · DOI
- Barrons RW, Murray KM, Richey RM (1992) Populations at risk for penicillin-induced seizures. Ann Pharmacother 26:26–29 · doi:10.1177/106002809202600106
- Barza M, Weinstein L (1976) Pharmacokinetics of the penicillins in man. Clin Pharmacokinet 1:297–308 · DOI
- Barza M, Furie B, Brown AE, Furie BC (1986) Defects in vitamin K-dependent carboxylation associated with moxalactam treatment. J Infect Dis 153:1166–1169 · doi:10.1093/infdis/153.6.1166
- Bennett JE, Dolin R, Blaser MJ (2014) Principles and practice of infectious diseases, 1. Elsevier health sciences
- Bethell H (1977) Photo-onycholysis caused by demethylchlortetracycline. Br Med J 2:96 · doi:10.1136/bmj.2.6079.96
- Beveridge TJ (1999) Structures of gram-negative cell walls and their derived membrane vesicles. J Bacteriol 181:4725–4733 · DOI · Paper page
- Bhandari R, Kaur IP (2013) Pharmacokinetics, tissue distribution and relative bioavailability of isoniazid-solid lipid nanoparticles. Int J Pharm 441:202–212 · DOI
- Bissuel F, Cotte L, de Montclos M, Rabodonirina M, Trepo C (1994) Absence of systemic absorption of oral paromomycin during long-term, high-dose treatment for cryptosporidiosis in AIDS. J Infect Dis 170:749–750 · doi:10.1093/infdis/170.3.749
- Blumberg HM, Burman WJ, Chaisson RE, Daley CL (2003) American thoracic society/centers for disease control and prevention/infectious diseases society of America: treatment of tuberculosis. Am J Respir Crit Care Med 167:603 · DOI · Paper page
- Blumenthal KG, Patil SU, Long AA (2012) The importance of vancomycin in drug rash with eosinophilia and systemic symptoms (DRESS) syndrome, allergy and asthma proceedings. OceanSide Publications, Inc, East Providence, pp 165–171
- Bo G (2000) Giuseppe Brotzu and the discovery of cephalosporins. Clin Microbiol Infect 6:6–8 · doi:10.1111/j.1469-0691.2000.tb02032.x
- Bosso JA (2005) The antimicrobial armamentarium: evaluating current and future treatment options. Pharmacotherapy 25:55S–62S · DOI
- Breen KJ, Bryant RE, Levinson JD, Schenker S (1972) Neomycin absorption in man: studies of oral and enema administration and effect of intestinal ulceration. Ann Intern Med 76:211–218 · doi:10.7326/0003-4819-76-2-211
- Brunner M, Pernerstorfer T, Mayer BX, Eichler HG, Müller M (2000) Surgery and intensive care procedures affect the target site distribution of piperacillin. Crit Care Med 28:1754–1759 · doi:10.1097/00003246-200006000-00009
- Buchholtz K, Larsen CT, Hassager C, Bruun NE (2009) Severity of gentamicin’s nephrotoxic effect on patients with infective endocarditis: a prospective observational cohort study of 373 patients. Clin Infect Dis 48:65–71 · DOI
- Carson JL, Strom BL, Duff A, Gupta A, Shaw M, Lundin FE, Das K (1993) Acute liver disease associated with erythromycins, sulfonamides, and tetracyclines. Ann Intern Med 119:576–583 · DOI
- Chatterjee V, Buchanan D, Friedmann A, Green M (1986) Ocular toxicity following ethambutol in standard dosage. Br J Dis Chest 80:288–291 · doi:10.1016/0007-0971(86)90066-5
- Chirumamilla SK, Padasala UD, Aravally H, Vuppalapati L, Cherukuri S (2017) Solubility and dissolution enhancement of Meropenem by Nano suspension approach. J Young Pharm 9(3):429–435 · DOI
- Chiu AM, Chuenkongkaew WL, Cornblath WT, Trobe JD, Digre KB, Dotan SA, Musson KH, Eggenberger ER (1998) Minocycline treatment and pseudotumor cerebri syndrome. Am J Ophthalmol 126:116–121 · DOI
- Chopra I (2011) Tetracyclines, antibiotic and chemotherapy (ninth edition). Elsevier, Amsterdam, pp 344–355
- Chung M, Schrogie JJ, Symchowicz S (1981) Pharmacokinetic study of sisomicin in humans. J Pharmacokinet Biopharm 9:535–551 · doi:10.1007/bf01061025
- Cohen ML (2000) Changing patterns of infectious disease. Nature 406:762 · DOI · Paper page
- Cohlan SQ (1963) Teratogenic agents and congenital malformations. J Pediatr 63:650–659 · DOI
- Cooper WO, Griffin MR, Arbogast P, Hickson GB, Gautam S, Ray WA (2002) Very early exposure to erythromycin and infantile hypertrophic pyloric stenosis. Arch Pediatr Adolesc Med 156:647–650 · DOI
- Craig WA (1997) The pharmacology of meropenem, a new carbapenem antibiotic. Clin Infect Dis 24:S266–S275 · DOI · Paper page
- Craven GR, Gavin R, Fanning T (1969) The transfer RNA binding site of the 30 S ribosome and the site of tetracycline inhibition, cold Spring Harbor symposia on quantitative biology. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, pp 129–137
- Dasgupta A (2012) Therapeutic drug monitoring: newer drugs and biomarkers. Academic Press, New York · DOI
- Davidson R, Cavalcanti R, Brunton JL, Bast DJ, de Azavedo JC, Kibsey P, Fleming C, Low DE (2002) Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia. N Engl J Med 346:747–750 · DOI · Paper page
- Demers P, Fraser D, Goldbloom R, Haworth J, LaRochelle J, MacLean R, Murray T (1968) Effects of tetracyclines on skeletal growth and dentition. A report by the nutrition Committee of the Canadian Paediatric Society. Can Med Assoc J 99:849
- Denamur S, Van Bambeke F, Mingeot-Leclercq M-P, Tulkens PM (2008) Apoptosis induced by aminoglycosides in LLC-PK1 cells: comparative study of neomycin, gentamicin, amikacin, and isepamicin using electroporation. Antimicrob Agents Chemother 52:2236–2238 · doi:10.1128/aac.01680-07
- Domagala JM (1994) Structure-activity and structure-side-effect relationships for the quinolone antibacterials. J Antimicrob Chemother 33:685–706 · DOI · Paper page
- Dong Z, Xie S, Zhu L, Wang Y, Wang X, Zhou W (2011) Preparation and in vitro, in vivo evaluations of norfloxacin-loaded solid lipid nanopartices for oral delivery. Drug Deliv 18:441–450 · DOI
- Driessen O, Sorgedrager N, Michel M, Kerrebijn K, Hermans J (1978) Pharmacokinetic aspects of therapy with ampicillin and kanamycin in new-born infants. Eur J Clin Pharmacol 13:449–457 · doi:10.1007/bf00566325
- Duggar BM (1948) Aureomycin: a product of the continuing search for new antibiotics. Ann N Y Acad Sci 51:177–181 · DOI · Paper page
- Eckman M, Johnson T, Riess R (1975) Partial deafness after erythromycin. N Engl J Med 292:649
- Edelstein PH (2004) Pneumococcal resistance to macrolides, lincosamides, ketolides, and streptogramin B agents: molecular mechanisms and resistance phenotypes. Clin Infect Dis 38:S322–S327 · DOI
- Ehrlich J, Bartz QR, Smith RM, Joslyn DA (1947) Chloromyeetin, a new antibiotic from a soil actinomycete. Science (Washington) 106(2757):417 · DOI · Paper page
- El-Kattan AF, Lee MS (2017) Oral bioavailability assessment: basics and strategies for drug discovery and development. Wiley, Hoboken · doi:10.1002/9781118916926
- El-Komy A (1995) Disposition kinetics and bioavailability of piperacillin and cephapirin in mares. Dtsch Tierarztl Wochenschr 102:244–248
- Ellsworth A, Christensen D, Volpone-McMahon M (1990) Prospective comparison of patient tolerance to enteric-coated vs nonenteric-coated erythromycin. J Fam Pract 31:265–270
- Elyasi S, Khalili H, Dashti-Khavidaki S, Mohammadpour A (2012) Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review. Eur J Clin Pharmacol 68:1243–1255 · DOI · Paper page
- Ensign LM, Cone R, Hanes J (2012) Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. Adv Drug Deliv Rev 64:557–570 · DOI · Paper page
- Eyster H (1943) Mechanism of sulfanilamide action and its interaction with p-amino benzoic acid. J Cell Comp Physiol 21:191–198 · doi:10.1002/jcp.1030210211
- Fabre J, Rudhardt M, Blanchard P, Regamey C (1976) Persistence of sisomicin and gentamicin in renal cortex and medulla compared with other organs and serum of rats. Kidney Int 10:444–449 · doi:10.1038/ki.1976.131
- Fainstein V, Bodey G, McCredie K, Keating M, Estey E, Bolivar R, Elting L (1983) Coagulation abnormalities induced by β-lactam antibiotics in cancer patients. J Infect Dis 148:745–750 · doi:10.1093/infdis/148.4.745
- Fanning WL, Gump DW, Sofferman RA (1977) Side effects of minocycline: a double-blind study. Antimicrob Agents Chemother 11:712–717 · DOI
- Faulkner R, Fernandez P, Lawrence G, Sia L, Falkowski A, Weiss A, Yacobi A, Silber B (1988) Absolute bioavailability of cefixime in man. J Clin Pharmacol 28:700–706 · doi:10.1002/j.1552-4604.1988.tb03203.x
- Finch R, Schürmann D, Collins O, Kubin R, McGivern J, Bobbaers H, Izquierdo J, Nikolaides P, Ogundare F, Raz R (2002) Randomized controlled trial of sequential intravenous (iv) and oral moxifloxacin compared with sequential iv and oral co-amoxiclav with or without clarithromycin in patients with community-acquired pneumonia requiring initial parenteral treatment. Antimicrob Agents Chemother 46:1746–1754 · DOI · Paper page
- Florek J, Caillard R, Kleitz F (2017) Evaluation of mesoporous silica nanoparticles for oral drug delivery–current status and perspective of MSNs drug carriers. Nanoscale 9:15252–15277 · DOI · Paper page
- Foster TS, Raehl CL, Wilson HD (1980) Disulfiram-like reaction associated with a parenteral cephalosporin. Am J Health Syst Pharm 37:858–859 · doi:10.1093/ajhp/37.6.858
- François B, Russell RJ, Murray JB, Aboul-ela F, Masquida B, Vicens Q, Westhof E (2005) Crystal structures of complexes between aminoglycosides and decoding a site oligonucleotides: role of the number of rings and positive charges in the specific binding leading to miscoding. Nucleic Acids Res 33:5677–5690 · DOI · Paper page
- Fraser TG, Stosor V, Wang Q, Allen A, Zembower TR (2005) Vancomycin and home health care. Emerg Infect Dis 11:1558 · DOI
- Fung AT, Hudson B, Billson FA (2011) Chloramphenicol–not so innocuous: a case of optic neuritis. BMJ Case Rep 2011:bcr1020103434
- Fuoco D (2012) Classification framework and chemical biology of tetracycline-structure-based drugs. Antibiotics 1:1 · DOI
- García-Carbonell MC, Granero L, Torres-Molina F, Aristorena J-C, Chesa-Jimenez J, Pla-Delfina J, Peris-Ribera J (1993) Nonlinear pharmacokinetics of cefadroxil in the rat. Drug Metab Dispos 21:215–217
- Geeaci J, Heilman F, Nichols D, Wellman W (1958) Antibiotic therapy of bacterial endocarditis. VII. Vancomycin for acute micrococcal endocarditis. Preliminary report, proceedings of staff meetings of the Mayo Clinic, pp 172–181
- Gips M, Soback S (1996) Norfloxacin nicotinate pharmacokinetics in unwearied and weaned calves. J Vet Pharmacol Ther 19:130–134 · doi:10.1111/j.1365-2885.1996.tb00025.x
- Green C, Cameron H, Julian G (1975) Recovery of polysome function of T4-infected Escherichia coli after brief treatment with chloramphenicol and rifampin. Antimicrob Agents Chemother 7:549–554 · doi:10.1128/aac.7.5.549
- Griffith R, Black H (1970) Cephalexin. Med Clin North Am 54:1229–1244 · doi:10.1016/s0025-7125(16)32589-5
- Hata H, Saeki S, Kimura T, Sugahara Y, Kuroda K (1999) Adsorption of taxol into ordered mesoporous silicas with various pore diameters. Chem Mater 11:1110–1119 · DOI
- Hebert AA, Sigman ES, Levy ML (1991) Serum sickness—like reactions from cefaclor in children. J Am Acad Dermatol 25:805–808 · doi:10.1016/s0190-9622(08)80973-5
- Hemaiswarya S, Kruthiventi AK, Doble M (2008) Synergism between natural products and antibiotics against infectious diseases. Phytomedicine 15:639–652 · DOI · Paper page
- Hens B, Brouwers J, Anneveld B, Corsetti M, Symillides M, Vertzoni M, Reppas C, Turner DB, Augustijns P (2014) Gastrointestinal transfer: in vivo evaluation and implementation in in vitro and in silico predictive tools. Eur J Pharm Sci 63:233–242 · DOI
- Hey H, Jørgensen F, Sørensen K, Hasselbalch H, Wamberg T (1982) Oesophageal transit of six commonly used tablets and capsules. Br Med J (Clin Res Ed) 285:1717–1719 · doi:10.1136/bmj.285.6356.1717
- Hinshaw H, Feldman W (1945) Streptomycin in treatment of clinical tuberculosis: a preliminary report, proceedings of staff meetings of the Mayo Clinic, pp 313–318
- Hopefl AW (1985) Aztreonam—an overview. Drug Intell Clin Pharm 19:171–175 · doi:10.1177/106002808501900301
- Hou C-D, Wang J-X, Le Y, Zou H-K, Zhao H (2012) Preparation of azithromycin nanosuspensions by reactive precipitation method. Drug Dev Ind Pharm 38:848–854 · DOI
- Humbert G, Leroy A, Fillastre J, Oksenhendler G (1978) Pharmacokinetics of netilmicin in the presence of normal or impaired renal function. Antimicrob Agents Chemother 14:40–44 · doi:10.1128/aac.14.1.40
- Humbert G, Spyker DA, Fillastre J, Leroy A (1979) Pharmacokinetics of amoxicillin: dosage nomogram for patients with impaired renal function. Antimicrob Agents Chemother 15:28–33 · doi:10.1128/aac.15.1.28
- Ingalls CS, Freimer EH (1992) Detection of antibiotic-induced platelet dysfunction in whole blood using flow cytometry. J Antimicrob Chemother 29:313–321 · doi:10.1093/jac/29.3.313
- Inman W, Rawson N (1983) Erythromycin estolate and jaundice. Br Med J (Clin Res Ed) 286:1954–1955 · doi:10.1136/bmj.286.6382.1954
- Iseman MD, Cohn DL, Sbarbaro JA (1993) Directly observed treatment of tuberculosis—we can’t afford not to try it. N Engl J Med 328:576–578 · DOI · Paper page
- Josefsson K, Bergan T (1982) Pharmacokinetics of phenoxymethylpenicillin in volunteers. Chemotherapy 28:241–246 · doi:10.1159/000238084
- Joukhadar C, Frossard M, Mayer BX, Brunner M, Klein N, Siostrzonek P, Eichler HG, Müller M (2001) Impaired target site penetration of β-lactams may account for therapeutic failure in patients with septic shock. Crit Care Med 29:385–391 · DOI · Paper page
- Kaplan SA, Weinfeld RE, Abruzzo CW, Lewis M (1972) Pharmacokinetic profile of sulfisoxazole following intravenous, intramuscular, and oral administration to man. J Pharm Sci 61:773–778 · DOI
- Karmody CS, Weinstein L (1977) Reversible sensorineural hearing loss with intravenous erythromycin lactobionate. Ann Otol Rhinol Laryngol 86:9–11 · doi:10.1177/000348947708600103
- Katapadi K, Kostandy G, Katapadi M, Hussain K, Schifter D (1997) A review of erythromycin-induced malignant tachyarrhythmia—torsade de pointes: a case report. Angiology 48:821–826 · DOI
- Keating GM, Perry CM (2005) Ertapenem. Drugs 65:2151–2178 · DOI
- Kelkar PS, Li JT-C (2001) Cephalosporin allergy. N Engl J Med 345:804–809 · DOI · Paper page
- Kerr RO, Cardamone J, Dalmasso AP, Kaplan ME (1972) Two mechanisms of erythrocyte destruction in penicillin-induced hemolytic anemia. N Engl J Med 287:1322–1325 · doi:10.1056/nejm197212282872604
- Kip AE, Schellens JH, Beijnen JH, Dorlo TP (2018) Clinical pharmacokinetics of systemically administered antileishmanial drugs. Clin Pharmacokinet 57:151–176 · DOI
- Klein JO, Finland M (1963) Nafcillin: antibacterial action in vitro and absorption and excretion in Normal young men. Am J Med Sci 246:10–26 · doi:10.1097/00000441-196307000-00002
- Kolkman W, Groeneveld J, Baur H, Verschuur H (2002) Ototoxicity induced by clarithromycin. Ned Tijdschr Geneeskd 146:1743–1745
- Kuhlmann J, Dalhoff A, Zeiler H-J (2012) Quinolone antibacterials, vol 127. Springer Science & Business Media, New York
- Leclercq R, Courvalin P (2002) Resistance to macrolides and related antibiotics in Streptococcus pneumoniae. Antimicrob Agents Chemother 46:2727–2734 · DOI · Paper page
- Libke RD, Clarke JT, Ralph ED, Luthy RP, Kirby WM (1975) Ticarcillin vs carbenicillin: clinical pharmacokinetics. Clin Pharmacol Therapeut 17:441–446 · doi:10.1002/cpt1975174441
- Lin C-H, Chen C-H, Lin Z-C, Fang J-Y (2017) Recent advances in oral delivery of drugs and bioactive natural products using solid lipid nanoparticles as the carriers. J Food Drug Anal 25:219–234 · DOI · Paper page
- Lipsky BA, Baker CA, McDonald LL, Suzuki NT (1999) Improving the appropriateness of vancomycin use by sequential interventions. Am J Infect Control 27:84–90 · doi:10.1016/s0196-6553(99)70086-6
- Lochhead J, Elston J (2003) Doxycycline induced intracranial hypertension. BMJ 326:641–642 · doi:10.1136/bmj.326.7390.641
- Lode H, Elvers A, Koeppe P, Borner K (1984) Comparative pharmacokinetics of apalcillin and piperacillin. Antimicrob Agents Chemother 25:105–108 · doi:10.1128/aac.25.1.105
- Longo G, Valenti C, Gandini G, Ferrara L, Bertesi M, Emilia G (1997) Azithromycin-induced intrahepatic cholestasis. Am J Med 102:217
- Loos U, Musch E, Jensen J, Mikus G, Schwabe H, Eichelbaum M (1985) Pharmacokinetics of oral and intravenous rifampicin during chronic administration. Klin Wochenschr 63:1205–1211 · DOI
- Low CL, Gopalakrishna K, Lye WC (2000) Pharmacokinetics of once daily intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol 11:1117–1121 · doi:10.1681/asn.v1161117
- Lynch SR, Puglisi JD (2001) Structural origins of aminoglycoside specificity for prokaryotic ribosomes1. J Mol Biol 306:1037–1058 · DOI
- MacGregor RR, Graziani AL (1997) Oral administration of antibiotics: a rational alternative to the parenteral route. Clin Infect Dis 24:457–467 · DOI
- Madison JF (1963) Tetracycline pigmentation of teeth. Arch Dermatol 88:58–59 · doi:10.1001/archderm.1963.01590190064008
- Manyan DR, Arimura GK, Yunis AA (1972) Chloramphenicol-induced erythroid suppression and bone marrow ferrochelatase activity in dogs. J Lab Clin Med 79:137–144
- Maraqa NF, Gomez MM, Rathore MH, Alvarez AM (2002) Higher occurrence of hepatotoxicity and rash in patients treated with oxacillin, compared with those treated with nafcillin and other commonly used antimicrobials. Clin Infect Dis 34:50–54 · DOI
- Marshall WF, Blair JE (1999) The cephalosporins, Mayo Clinic proceedings. Elsevier, Amsterdam, pp 187–195
- Martinez MN, Amidon GL (2002) A mechanistic approach to understanding the factors affecting drug absorption: a review of fundamentals. J Clin Pharmacol 42:620–643 · DOI · Paper page
- Mccaffrey RP, Halsted CH, Wahab MFA, Robertson RP (1971) Chloramphenicol-induced hemolysis in Caucasian glucose-6-phosphate dehydrogenase deficiency. Ann Intern Med 74:722–726 · DOI
- Meyers B, Hirschman S, Strougo L, Srulevitch E (1980) Comparative study of piperacillin, ticarcillin, and carbenicillin pharmacokinetics. Antimicrob Agents Chemother 17:608–611 · DOI
- Miller AD, Ball AM, Bookstaver PB, Dornblaser EK, Bennett CL (2011) Epileptogenic potential of carbapenem agents: mechanism of action, seizure rates, and clinical considerations. Pharmacotherapy 31:408–423 · DOI
- Mitchell JR, Zimmerman HJ, Ishak KG, Thorgeirsson UP, Timbrell JA, Snodgrass WR, Nelson SD (1976) Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis. Ann Intern Med 84:181–192 · DOI · Paper page
- Mizuno N, Nishikata M, Morita E, Miyake K (1986) Gastrointestinal absorption of sulfaguanidine in neonatal and adult rats. Aust J Pharm 9:787–792
- Moffitt JM, Cooley RO, Olsen NH, Hefferren JJ (1974) Prediction of tetracycline-induced tooth discoloration. J Am Dent Assoc 88:547–552 · doi:10.14219/jada.archive.1974.0150
- Mori H, Takahashi K, Mizutani T (2007) Interaction between valproic acid and carbapenem antibiotics. Drug Metab Rev 39:647–657 · DOI
- Musser J, Anderson K (2001) Bioavailability and disposition of sodium and procaine penicillin G (benzylpenicillin) administered orally with milk to calves. J Vet Pharmacol Ther 24:161–169 · doi:10.1046/j.1365-2885.2001.00325.x
- Myers AL, Gaedigk A, Dai H, James LP, Jones BL, Neville KA (2012) Defining risk factors for red man syndrome in children and adults. Pediatr Infect Dis J 31:464 · DOI
- Namba S, Igari T, Nishiyama K, Hashimoto K, Takemura T, Kimura K (1991) A case of pyrazinamide-associated myoglobinuric renal failure. Jpn J Med 30:468–472 · doi:10.2169/internalmedicine1962.30.468
- Nathwani D, Wood MJ (1993) Penicillins. Drugs 45:866–894 · DOI
- Nauta E, Mattie H (1975) Pharmacokinetics of flucloxacillin and cloxacillin in healthy subjects and patients on chronic intermittent haemodialysis. Br J Clin Pharmacol 2:111–121 · doi:10.1111/j.1365-2125.1975.tb01566.x
- Nightingale CH, Greene DS, Quintiliani R (1975) Pharmacokinetics and clinical use of cephalosporin antibiotics. J Pharm Sci 64:1899–1927 · doi:10.1002/jps.2600641202
- Nordström L, Ringbert H, Cronberg S, Tjernström O, Walder M (1990) Does administration of an aminoglycoside in a single daily dose affect its efficacy and toxicity? J Antimicrob Chemother 25:159–173 · DOI
- Norrby SR (1987) Side effects of cephalosporins. Drugs 34:105–120 · DOI
- Owens RC Jr, Ambrose PG (2005) Antimicrobial safety: focus on fluoroquinolones. Clin Infect Dis 41:S144–S157 · DOI · Paper page
- Pai MP, Cottrell ML, Kashuba AD, Bertino JS (2014) Pharmacokinetics and pharmacodynamics of anti-infective agents, Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. Elsevier, Amsterdam
- Pestka S (1971) Inhibitors of ribosome functions. Annu Rev Microbiol 25:487–562 · DOI · Paper page
- Pillai S, Eliopoulos G, Moellering R (2010) Principles of anti-infective therapy. Principles and practice of infectious diseases, 7th edn. Churchill Livingston Elsevier, Philadelphia, PA, pp 267–278
- Piscitelli S, Danziger L, Rodvold K (1992) Clarithromycin and azithromycin: new macrolide antibiotics. Clin Pharm 11:137–152
- Pittinger C, Adamson R (1972) Antibiotic blockade of neuromuscular function. Annu Rev Pharmacol 12:169–184 · doi:10.1146/annurev.pa.12.040172.001125
- Pouretedal HR (2014) Preparation and characterization of azithromycin nanodrug using solvent/antisolvent method. Int Nano Lett 4:103 · doi:10.1007/s40089-014-0103-x
- Price EJ, Venables PJ (1995) Drug-induced lupus. Drug Saf 12:283–290 · doi:10.2165/00002018-199512040-00008
- Radwanski E, Batra V, Cayen M, Korduba C, Cutler D, Affrime M, Nomeir A, Lin C (1997) Pharmacokinetics of isepamicin following a single administration by intravenous infusion or intramuscular injections. Antimicrob Agents Chemother 41:1794–1796 · doi:10.1128/aac.41.8.1794
- Rando RR (2001) Aminoglycoside binding to human and bacterial A-site rRNA decoding region constructs. Bioorg Med Chem 9:2601–2608 · DOI
- Ray WA, Murray KT, Meredith S, Narasimhulu SS, Hall K, Stein CM (2004) Oral erythromycin and the risk of sudden death from cardiac causes. N Engl J Med 351:1089–1096 · DOI · Paper page
- Resistant BLPM (2007) Saponins from Eugenia jambolana with antibacterial activity against beta-lactamase producing methicillin resistant Staphylococcus aureus. Res J Med Pianti 1:1–6
- Rich ML, Ritterhoff RJ, Hoffmann RJ (1950) A fatal case of aplastic anemia following chloramphenicol (chloromycetin) therapy. Ann Intern Med 33:1459–1467 · doi:10.7326/0003-4819-33-6-1459
- Romano A, Torres M, Namour F, Mayorga C, Artesani M, Venuti A, Guéant J, Blanca M (2002) Immediate hypersensitivity to cephalosporins. Allergy 57:52–57 · DOI
- Ruoff JW, Sams R (1985) Pharmacokinetics and bioavailability of cephalothin in horse mares. Am J Vet Res 46:2085–2090
- Saivin S, Houin G (1988) Clinical pharmacokinetics of doxycycline and minocycline. Clin Pharmacokinet 15:355–366 · DOI · Paper page
- Sams R, Ruoff JW (1985) Pharmacokinetics and bioavailability of cefazolin in horses. Am J Vet Res 46:348–352
- Sandoval RM, Reilly JP, Running W, Campos SB, Santos JR, Phillips CL, Molitoris BA (2006) A non-nephrotoxic gentamicin congener that retains antimicrobial efficacy. J Am Soc Nephrol 17:2697–2705 · doi:10.1681/asn.2005101124
- SanFilippo JA (1976) Infantile hypertrophic pyloric stenosis related to ingestion of erythromycine estolate: a report of five cases. J Pediatr Surg 11:177–180 · DOI
- Sanwikarja S, Kauffmann R, Serlie J (1989) Tubulointerstitial nephritis associated with pyrazinamide. Neth J Med 34:40–46
- Sawant KK, Patel MH, Patel K (2016) Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro–in vivo evaluations. Drug Dev Ind Pharm 42:758–768 · doi:10.3109/03639045.2015.1104344
- Schentag JJ, Ballow CH (1991) Tissue-directed pharmacokinetics. Am J Med 91:S5–S11 · DOI · Paper page
- Schultz JC, Adamson JS Jr, Workman WW, Norman TD (1963) Fatal liver disease after intravenous administration of tetracycline in high dosage. N Engl J Med 269:999–1004 · DOI · Paper page
- Segal JL, Brunnemann SR, Gray DR (1988) Gentamicin bioavailability and single-dose pharmacokinetics in spinal cord injury. Drug Intell Clin Pharm 22:461–465 · doi:10.1177/106002808802200603
- Shaffer D, Singer S, Korvick J, Honig P (2002) Concomitant risk factors in reports of torsades de pointes associated with macrolide use: review of the United States Food and Drug Administration adverse event reporting system. Clin Infect Dis 35:197–200 · DOI
- Sharma A, Kumar Arya D, Dua M, Chhatwal GS, Johri AK (2012) Nano-technology for targeted drug delivery to combat antibiotic resistance. Taylor & Francis, London · DOI
- Sharma M, Gupta N, Gupta S (2016) Implications of designing clarithromycin loaded solid lipid nanoparticles on their pharmacokinetics, antibacterial activity and safety. RSC Adv 6:76621–76631 · DOI
- Shearer M, Bechtold H, Andrassy K, Koderisch J, McCarthy P, Trenk D, Jähnchen E, Ritz E (1988) Mechanism of cephalosporin-induced hypoprothrombinemia: relation to cephalosporin side chain, vitamin K metabolism, and vitamin K status. J Clin Pharmacol 28:88–95 · doi:10.1002/j.1552-4604.1988.tb03106.x
- Shils ME (1963) Renal disease and the metabolic effects of tetracycline. Ann Intern Med 58:389–408 · doi:10.7326/0003-4819-58-3-389
- Shively ML, Thompson DC (1995) Oral bioavailability of vancomycin solid-state emulsions. Int J Pharm 117:119–122 · doi:10.1016/0378-5173(94)00331-x
- Shyu W, Shah V, Campbell D, Wilber R, Pittman K, Barbhaiya R (1992) Oral absolute bioavailability and intravenous dose-proportionality of Cefprozil in humans. J Clin Pharmacol 32:798–803 · doi:10.1002/j.1552-4604.1992.tb03885.x
- Siddiqui K, Waris A, Akber H, Munir K, Mir M, Khan MW, Aman W (2017) Physicochemical modifications and Nano particulate strategies for improved bioavailability of poorly water soluble drugs. Pharmaceut Nanotechnol 5:276–284
- Signs S, Tan J, Salstrom S, File T (1992) Pharmacokinetics of imipenem in serum and skin window fluid in healthy adults after intramuscular or intravenous administration. Antimicrob Agents Chemother 36:1400–1403 · doi:10.1128/aac.36.7.1400
- Singh M, Varshneya C, Telang R, Srivastava A (2005) Alteration of pharmacokinetics of oxytetracycline following oral administration of Piper longum in hens. J Vet Sci 6:197–200 · doi:10.4142/jvs.2005.6.3.197
- Smith K, Leyden JJ (2005) Safety of doxycycline and minocycline: a systematic review. Clin Ther 27:1329–1342 · DOI · Paper page
- Smith CL, Powell K (2000) Review of the sulfonamides and trimethoprim. Pediatr Rev 21:368–371 · doi:10.1542/pir.21-11-368
- Smith AL, Weber A (1983) Pharmacology of chloramphenicol. Pediatr Clin N Am 30:209–236 · doi:10.1016/s0031-3955(16)34330-9
- Somogyi AA, Bochner F, Hetzel D, Williams DB (1995) Evaluation of the intestinal absorption of erythromycin in man: absolute bioavailability and comparison with enteric coated erythromycin. Pharm Res 12:149–154 · DOI
- Sörgel F, Kinzig M (1993) Pharmacokinetics of gyrase inhibitors, part 1: basic chemistry and gastrointestinal disposition. Am J Med 94:44S–55S · DOI
- Spyker DA, Rugloski RJ, Vann RL, O’Brien WM (1977) Pharmacokinetics of amoxicillin: dose dependence after intravenous, oral, and intramuscular administration. Antimicrob Agents Chemother 11:132–141 · DOI
- Staib AH, Beermann D, Harder S, Fuhr U, Liermann D (1989) Absorption differences of ciprofloxacin along the human gastrointestinal tract determined using a remote-control drug delivery device (HF-capsule). Am J Med 87:S66–S69 · DOI
- Suarez CR, Ow EP (1992) Chloramphenicol toxicity associated with severe cardiac dysfunction. Pediatr Cardiol 13:48–51 · doi:10.1007/bf00788231
- Suber RL, Lee C, Torosian G, Edds GT (1981) Pharmacokinetics of sulfisoxazole compared in humans and two monogastric animal species. J Pharm Sci 70:981–984 · doi:10.1002/jps.2600700903
- Sutherland JM (1959) Fatal cardiovascular collapse of infants receiving large amounts of chloramphenicol. AMA J Dis Child 97:761–767
- Swabb EA, Sugerman A, Stern M (1983) Oral bioavailability of the monobactam aztreonam (SQ 26,776) in healthy subjects. Antimicrob Agents Chemother 23:548–550 · doi:10.1128/aac.23.4.548
- Swartz MN (1997) Use of antimicrobial agents and drug resistance. N Engl J Med 337(7):491–492 · DOI · Paper page
- Sykes R, Bonner D (1985) Discovery and development of the monobactams. Rev Infect Dis 7:S579–S593 · doi:10.1093/clinids/7.supplement_4.s579
- Tod M, Padoin C, Petitjean O (2000) Clinical pharmacokinetics and pharmacodynamics of isepamicin. Clin Pharmacokinet 38:205–223 · DOI
- Tomé AM, Filipe A (2011) Quinolones. Drug Saf 34:465–488 · DOI
- Turner M, Aziz SR (2002) Management of the pregnant oral and maxillofacial surgery patient. J Oral Maxillofac Surg 60:1479–1488 · doi:10.1053/joms.2002.36132
- Uppal R, Verma S, Verma V, Garg S (1997) Comparative pharmacokinetics of amikacin following a single intramuscular or subcutaneous administration in goats (Capra hircus). Vet Res 28:565–570
- Van Bambeke F, Barcia-Macay M, Lemaire S, Tulkens PM (2006) Cellular pharmacodynamics and pharmacokinetics of antibiotics: current views and perspectives. Curr Opin Drug Discov Develop 9:218
- Verbist L, Tjandramaga T, Mullie A, Van Hecken A, Verbesselt R, De Schepper P (1982) Comparative study of in vitro antimicrobial activity and human pharmacokinetics of Dibekacin and tobramycin. Acta Clin Belg 37:148–157 · doi:10.1080/22953337.1982.11718857
- Vial T, Biour M, Descotes J, Trepo C (1997) Antibiotic-associated hepatitis: update from 1990. Ann Pharmacother 31:204–220 · DOI
- Vogelman B, Craig WA (1986) Kinetics of antimicrobial activity. J Pediatr 108:835–840 · DOI · Paper page
- Von Drygalski A, Curtis BR, Bougie DW, McFarland JG, Ahl S, Limbu I, Baker KR, Aster RH (2007) Vancomycin-induced immune thrombocytopenia. N Engl J Med 356:904–910 · DOI · Paper page
- Wallace RJ Jr, Brown BA, Griffith DE (1993) Drug intolerance to high-dose clarithromycin among elderly patients. Diagn Microbiol Infect Dis 16:215–221 · DOI
- Weber WW, Hein DW (1979) Clinical pharmacokinetics of isoniazid. Clin Pharmacokinet 4:401–422 · DOI · Paper page
- Werner JC, Whitman V, Schuler HG, Fripp RR, Rannels AM, Kasales CJ, LaNoue KF (1985) Acute myocardial effects of chloramphenicol in newborn pigs: a possible insight into the gray baby syndrome. J Infect Dis 152:344–350 · DOI
- Williams PE, Harding SM (1984) The absolute bioavailability of oral cefuroxime axetil in male and female volunteers after fasting and after food. J Antimicrob Chemother 13:191–196 · DOI
- Winckler K (1981) Tetracycline ulcers of the oesophagus. Endoscopy, histology and roentgenology in two cases, and review of the literature. Endoscopy 13:225–228 · doi:10.1055/s-2007-1021691
- Wise EM, Park JT (1965) Penicillin: its basic site of action as an inhibitor of a peptide cross-linking reaction in cell wall mucopeptide synthesis. Proc Natl Acad Sci 54:75–81 · DOI · Paper page
- Wolkenstein P, Charue D, Laurent P, Revuz J, Roujeau J-C, Bagot M (1995) Metabolic predisposition to cutaneous adverse drug reactions: role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants. Arch Dermatol 131:544–551 · doi:10.1001/archderm.1995.01690170046006
- Wood M, Farrell W, Kattan S, Williams J (1975) Activity of minocycline and tetracycline against respiratory pathogens related to blood levels. J Antimicrob Chemother 1:323–331 · doi:10.1093/jac/1.3.323
- Woolf D (1965) Chloramphenicol blindness. BMJ Publishing Group, London
- Xie J, Talaska AE, Schacht J (2011) New developments in aminoglycoside therapy and ototoxicity. Hear Res 281:28–37 · DOI · Paper page
- Yates AB (2008) Management of patients with a history of allergy to beta-lactam antibiotics. Am J Med 121:572–576 · DOI
- Yunis A (1973) Chloramphenicol induced bone marrow suppression, Seminars in hematology. WB Saunders Ltd, Philadelphia, pp 225–234
- Zhu M, Burman WJ, Jaresko GS, Berning SE, Jelliffe RW, Peloquin CA (2001) Population pharmacokinetics of intravenous and intramuscular streptomycin in patients with tuberculosis. Pharmacotherapy 21:1037–1045 · doi:10.1592/phco.21.13.1037.34625
200 of 201 shown
Cited by
Abu Ershaid, J. M., Abudoleh, S. M., Lafi, D. N., & Dahshan, N. A. (2025) · Polymers · doi:10.3390/polym17212912 · Cited by 5
Metadata
- Authors
- Ullah, I., Ali, E., & Fakhar-ud-Din
- Venue
- Emerging Contaminants and Associated Treatment Technologies
- Publisher
- Springer International Publishing
- Published
- 2020
- Pages
- 211-238
- ISSN
- 2524-6402
- 2524-6410
- Cited by
- 9
- References
- 0
- Language
- en
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bioavailability of Antibiotics and Their Toxicity. https://app.cochat.ai/papers/10.1007/978-3-030-40422-2_10
- The paper
- Ullah, I., Ali, E., & Fakhar-ud-Din. (2020). Bioavailability of Antibiotics and Their Toxicity. Emerging Contaminants and Associated Treatment Technologies. https://doi.org/10.1007/978-3-030-40422-2_10
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.